Evidence map›Paper›PMID 36202818›Full record

ArticleNature communications2022

Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection.

Guochao Wei, Naseer Iqbal, Valentine V Courouble, Ashwanth C Francis, Parmit K Singh, Arpa Hudait, Arun S Annamalai, Stephanie Bester, Szu-Wei Huang, Nikoloz Shkriabai and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 54 citations in OpenAlex.

  1. Mechanistic Insights into HIV-1 Capsid Interactions with CPSF6.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. MX2 Mediates Collapse of the HIV-1 Capsid.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Guochao WeiDivision of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA.ORCID 0000-0002-7768-2404
Naseer IqbalDepartment of Biochemistry & Molecular Genetics, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Valentine V CouroubleDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, 33458, USA.
Ashwanth C FrancisInstitute of Molecular Biophysics, Department of Biological Sciences, Florida State University, Tallahassee, FL, 32306, USA.
Parmit K SinghDepartment of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.ORCID 0000-0002-9657-2526
Arpa HudaitDepartment of Chemistry, Chicago Center for Theoretical Chemistry, Institute for Biophysical Dynamics, and James Franck Institute, The University of Chicago, Chicago, IL, 60637, USA.
Arun S AnnamalaiDivision of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Stephanie BesterDivision of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA.ORCID 0000-0001-7137-0090
Szu-Wei HuangDivision of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Nikoloz ShkriabaiDivision of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Lorenzo BrigantiDivision of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA.ORCID 0000-0003-2237-6896
Reed HaneyDivision of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Vineet N KewalRamaniCenter for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.ORCID 0000-0002-3263-4257
Gregory A VothDepartment of Chemistry, Chicago Center for Theoretical Chemistry, Institute for Biophysical Dynamics, and James Franck Institute, The University of Chicago, Chicago, IL, 60637, USA.ORCID 0000-0002-3267-6748
Alan N EngelmanDepartment of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.ORCID 0000-0002-9709-2591
Gregory B MelikyanDepartment of Pediatrics, Emory University, Atlanta, GA, 30322, USA.
Patrick R GriffinDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, 33458, USA.ORCID 0000-0002-3404-690X
Francisco AsturiasDepartment of Biochemistry & Molecular Genetics, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Mamuka KvaratskheliaDivision of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO, 80045, USA. mamuka.kvaratskhelia@cuanschutz.edu.ORCID 0000-0003-3800-0033
University of Colorado Anschutz Medical Campus · USChicago Institute for Psychoanalysis · USHarvard University · USNational Cancer Institute · USScripps Research Institute · USEmory University · USFlorida State University · US

Funding

Structural Biology CoreU54AI170855 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Bruce Edward Torbett · 2022 to 2026
$36.7M
X-ray Crystallographic Fragment Screening CoreU54AI150472 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI OLSON, ARTHUR J. · 2019 to 2021
$15.7M
Nuclear Localization of HIV-1 Preintegration ComplexesR01AI052014 · NIAID · DANA-FARBER CANCER INSTITUTE · PI ENGELMAN, ALAN N. · 2003 to 2025
$11.4M
Ultra-potent HIV capsid inhibitorsR01AI157802 · NIAID · UNIVERSITY OF COLORADO DENVER · PI JAMES R FUCHS, Mamuka Kvaratskhelia · 2020 to 2026
$7.1M
Imaging of Single HIV-1 Uncoating and Transport to the nucleusR01AI129862 · NIAID · EMORY UNIVERSITY · PI KVARATSKHELIA, MAMUKA, MELIKIAN, GREGORY B · 2017 to 2025
$5.4M
Roles of HIV-1 capsid-binding FG-motif containing cellular cofactors in infectionR01AI162665 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Mamuka Kvaratskhelia, Gregory B Melikian · 2022 to 2026
$3.9M
Beagle-3: A Shared GPU Cluster for Biomolecular SciencesS10OD028655 · OD · UNIVERSITY OF CHICAGO · PI ROUX, BENOIT · 2020 to 2020
$2.0M
Training Program for Antiretroviral Discovery, Evaluation and Application Research (ADEAR)T32AI150547 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Joshua Adam Barocas, Kristine Mace Erlandson · 2020 to 2026
$1.3M
Delineating a role for CA in HIV-1 nuclear transport to sites of integrationR21AI145541 · NIAID · FLORIDA STATE UNIVERSITY · PI FRANCIS, ASHWANTH CHRISTOPHER · 2020 to 2021
$426k
NIAID NIH HHS R01 AI052014NIAID NIH HHS R01 AI129862NIAID NIH HHS R01 AI157802NIAID NIH HHS R01 AI162665NIAID NIH HHS R21 AI145541NIAID NIH HHS T32 AI150547NIAID NIH HHS U54 AI150472NIAID NIH HHS U54 AI170855NIH HHS S10 OD028655
6 · The paper itself

Abstract

Cellular proteins CPSF6, NUP153 and SEC24C play crucial roles in HIV-1 infection. While weak interactions of short phenylalanine-glycine (FG) containing peptides with isolated capsid hexamers have been characterized, how these cellular factors functionally engage with biologically relevant mature HIV-1 capsid lattices is unknown. Here we show that prion-like low complexity regions (LCRs) enable avid CPSF6, NUP153 and SEC24C binding to capsid lattices. Structural studies revealed that multivalent CPSF6 assembly is mediated by LCR-LCR interactions, which are templated by binding of CPSF6 FG peptides to a subset of hydrophobic capsid pockets positioned along adjoining hexamers. In infected cells, avid CPSF6 LCR-mediated binding to HIV-1 cores is essential for functional virus-host interactions. The investigational drug lenacapavir accesses unoccupied hydrophobic pockets in the complex to potently impair HIV-1 inside the nucleus without displacing the tightly bound cellular cofactor from virus cores. These results establish previously undescribed mechanisms of virus-host interactions and antiviral action.

Indexed as

Anti-HIV AgentsHIV-1HIV InfectionsPrionsCapsid ProteinsDrugs, InvestigationalGlycineHost Microbial InteractionsHumansmRNA Cleavage and Polyadenylation FactorsNuclear Pore Complex ProteinsPhenylalanineVirus IntegrationAnti-HIV AgentsCapsid ProteinsDrugs, InvestigationalGlycinemRNA Cleavage and Polyadenylation FactorsNuclear Pore Complex ProteinsNUP153 protein, humanPhenylalaninePrions

Identifiers

PMID36202818
PMCPMC9537594
OpenAlexW4302290892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.